Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b study
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b study
Ezequiel Córdova, Essack Mitha, Josep M. Llibre, Veronica Bainbridge et al.
Journal
EClinicalMedicine
Topics
HIV/AIDS drug development and treatment
article
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b study
Ezequiel Córdova, Essack Mitha, Josep M. Llibre, Veronica Bainbridge, Anja Potthoff, Brian Wynne, Oksana Chernova, Max Lataillade, Cindy Fishman, Samit R. Joshi, Ying Zhang, Moti N. Ramgopal, J Oyee, Sebastián A. Núñez, Aditya Joshi, Jerry Jeffrey, Choy Man, Antonella Castagna
article en
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 89
Institutions
Vita-Salute San Raffaele University (IT), GlaxoSmithKline (India) (IN), GlaxoSmithKline (United States) (US), Fundación para la Investigación, Docencia y Prevención del Cáncer (AR), Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR), Hospital Universitari Germans Trias i Pujol (ES), Samara Regional Clinical Oncology Center (RU), Indian River State College (US), Ruhr University Bochum (DE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b study — Ezequiel Córdova, Essack Mitha, et al. · EClinicalMedicine (2025) | TGRS Research Map | TGRS